AzTrials
AzTrials

Pelvic Organ ProlapseNCT05189665

the Anatomical Reduction and Functional Recovery Effects of Two Transvaginal Apical Slings on Pelvic Organ Prolapse

A study testing Extraperitoneal high sacral ligament suspension surgery and Sacrospinous ligament fixation in people with Pelvic Organ Prolapse, run by Peking University People's Hospital at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The study is a prospective study at a single institution. Investigators create strict inclusion and exclusion criteria, selecting 124 patients with POP(≥II degree and have symptoms that need operation) . 62 patients in the intervention group accept extraperitoneal high uterosacral ligament suspension. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Pelvic Organ Prolapse
What is being tested?
Extraperitoneal high sacral ligament suspension surgery and Sacrospinous ligament fixation
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
124 participants
Where
1 siteChina
Study dates
1 Oct 2021to Apr 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age ≥30 years old;
  • pelvic organ prolapse, with or without abnormal urination or defecation or sexual disturbance, which affects the quality of life
  • Pelvic organ prolapse quantitation (POP-Q) is greater than or equal to Those who are in stage II and have symptoms and require surgery
  • The patient agrees to conduct the study and can be followed up on time.

Who cannot join

  • Those who cannot tolerate surgery and anesthesia
  • Those who need to remove the uterus
  • Those who have removed the uterus
  • Those who cannot be followed up on time.

Trial locations and contacts

1 site in 1 country.

xiuli sun, professor contact

010-88324354

sunxiuli03351@126.com

China1 site, 1 recruiting
  • Peking University People's Hospital

    Beijing, Beijing Municipality, 100044

    xiuli sun, professor, 010-88324354, sunxiuli03351@126.com

    jiaoyang song, doctor, 010-88324354, 18846453272@163.com

    Recruiting

Other trials in China

About this study

Official title: A Randomized Controlled Study on the Anatomical Reduction and Functional Recovery Effects of Two Transvaginal Apical Slings on Pelvic Organ Prolapse

The study is a prospective study at a single institution. Investigators create strict inclusion and exclusion criteria, selecting 124 patients with POP(≥II degree and have symptoms that need operation) . 62 patients in the intervention group accept extraperitoneal high uterosacral ligament suspension. The other 62 patients in the other group accept sacrospinous ligament suspension.

Read the detailed description

Investigators evaluate all women's operation method, operation time, bleed volume, overactive bladder questionnaire, PFDI-20,ICIQ-SF, I-QoL, PISQ-12, PFIQ-7, UDI-6, pre- and post-operation (at 1 month, 3 months, 6months and 1 year).

Being tested
Extraperitoneal high sacral ligament suspension surgery, Sacrospinous ligament fixation
Keywords
Extraperitoneal high uterosacral ligament suspension
Medical subject headings
Pelvic Organ Prolapse

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Extraperitoneal high sacral ligament suspension surgeryProcedure or surgery

    The extraperitoneal high sacral ligament suspension surgery is to shorten the bilateral uterosacral ligaments .

  • Sacrospinous ligament fixationProcedure or surgery

    The sacrospinous ligament fixation surgery is to open the front and back peritoneum through the vagina and shorten the bilateral uterosacral ligaments.

Study groups in NCT05189665
Study groupRoleWhat they receive
Extraperitoneal high sacral ligament suspension GroupExperimentalWe will recruit 62 POP patients ,and perform Surgery Extraperitoneal high sacral ligament suspension surgery on them.
Receives: Procedure: Extraperitoneal high sacral ligament suspension surgery
Sacrospinous Ligament Suspension GroupActive comparatorWe will recruit 62 POP patients ,and perform sacrospinous ligament suspension surgery on them.
Receives: Procedure: Sacrospinous ligament fixation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. changes in POP-Q score at different time nodes

    Gynecological examination

    Measured: pre-operation and post-operation(at 1month, 3 month, 6 month and a year)

Secondary outcomes (8)
  1. UDI-6 scores at different time nodes UDI-6

    Questionnaires on lower urinary tract symptoms and quality of life

    Measured: pre-operation and post-operation(at 1month, 3 month, 6 month and a year)

  2. Postoperative urinary incontinence assessment

    One hour pad test

    Measured: post-operation(at 1month, 3 month, 6 month and a year)

  3. OABss score at different time nodes

    Questionnaires lower urinary tract symptoms

    Measured: post-operation(at 1month, 3 month, 6 month and a year)

  4. PFDI-20 score at different time nodes

    Questionnaires on pelvic floor function and lower urinary tract symptoms and quality of life

    Measured: post-operation(at 1month, 3 month, 6 month and a year)

  5. ICIQ-SF score at different time nodes

    Questionnaires on lower urinary tract symptoms

    Measured: post-operation(at 1month, 3 month, 6 month and a year)

  6. I-QoL score at different time nodes

    Questionnaires on lower urinary tract symptoms and quality of life

    Measured: post-operation(at 1month, 3 month, 6 month and a year)

  7. PISQ-12 score at different time nodes

    Questionnaires on pelvic floor function and lower urinary tract symptoms and sexual quality of life

    Measured: post-operation(at 1month, 3 month, 6 month and a year)

  8. PFIQ-7 score at different time nodes

    Questionnaires on pelvic floor function and quality of life

    Measured: post-operation(at 1month, 3 month, 6 month and a year)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jan 2022
  2. Study start1 Oct 2021
  3. Primary completionDec 2022 (estimated)
  4. Study completionApr 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
124 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05189665
Sponsor's protocol ID
Pkuh4
Status last verified
Oct 2021
First submitted
23 Nov 2021
Last updated
12 Jan 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Extraperitoneal high uterosacral ligament sling is effective in treating pelvic organ prolapse, and postoperative anatomical recovery is good, not inferior to traditional sacral ligament sling

Questions about this trial

What is this clinical trial studying?

A study testing Extraperitoneal high sacral ligament suspension surgery and Sacrospinous ligament fixation in people with Pelvic Organ Prolapse, run by Peking University People's Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 12 Jan 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact xiuli sun, professor (010-88324354, sunxiuli03351@126.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

changes in POP-Q score at different time nodes (time frame: pre-operation and post-operation(at 1month, 3 month, 6 month and a year)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jan 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in